Elion Therapeutics is a privately held, clinical-stage biotechnology company developing treatments for life-threatening invasive fungal infections (IFIs). Formerly known as Sfunga Therapeutics, the company was founded on the belief that mechanistic insight into natural products enables targeted optimization of them. Its lead candidate, SF001, is a next-generation polyene antifungal — a rationally designed analog of amphotericin B intended to retain broad fungicidal activity while mitigating the systemic toxicity that limits the parent molecule. SF001 received FDA Qualified Infectious Disease Product (QIDP) and Fast Track designations in 2023 and has advanced from a first-in-human single-ascending-dose study into multiple-ascending-dose evaluation. Elion closed an $81 million Series B in June 2024 led by Deerfield Management and the AMR Action Fund, with participation from Illinois Ventures. Elion is a therapeutics developer, not a software vendor: it publishes no developer program, public API, or machine-readable API contract, and this profile records that absence rather than any API surface.
Elion Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Therapeutics, and Life Sciences.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: elion-therapeutics
name: Elion Therapeutics
description: 'Elion Therapeutics is a privately held, clinical-stage biotechnology company developing treatments for life-threatening
invasive fungal infections (IFIs). Formerly known as Sfunga Therapeutics, the company was founded on the belief that mechanistic
insight into natural products enables targeted optimization of them. Its lead candidate, SF001, is a next-generation polyene
antifungal — a rationally designed analog of amphotericin B intended to retain broad fungicidal activity while mitigating
the systemic toxicity that limits the parent molecule. SF001 received FDA Qualified Infectious Disease Product (QIDP) and
Fast Track designations in 2023 and has advanced from a first-in-human single-ascending-dose study into multiple-ascending-dose
evaluation. Elion closed an $81 million Series B in June 2024 led by Deerfield Management and the AMR Action Fund, with
participation from Illinois Ventures. Elion is a therapeutics developer, not a software vendor: it publishes no developer
program, public API, or machine-readable API contract, and this profile records that absence rather than any API surface.'
url: https://raw.githubusercontent.com/api-evangelist/elion-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- security
generated: '2026-09-02'
method: derived
specificationVersion: '0.23'
created: '2026-08-12'
modified: '2026-08-12'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Therapeutics
- Life Sciences
- Anti-Infectives
- Drug Development
- Clinical Stage
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/elion-therapeutics-domain-security.yml
- type: Website
url: https://eliontx.com/
- type: Company
url: https://forgeglobal.com/elion-therapeutics_stock/
- type: LLMsTxt
url: llms/elion-therapeutics-llms.txt
x-enrichment:
date: '2026-08-12'
status: minimal
artifacts_added: 3
pass: local-v1
x-coverage:
state: none
reason: not-a-software-company
detail: Elion Therapeutics is a clinical-stage antifungal drug developer whose only web property is a WordPress marketing
site — the origin answers HTTP 404 to every /.well-known/ path and to /llms.txt, and there is no developer portal, GitHub
organization, or API of any kind to profile.
evidence:
- url: https://eliontx.com/.well-known/api-catalog
status: 404
- url: https://eliontx.com/llms.txt
status: 404
- url: https://eliontx.com/robots.txt
status: 200
- url: https://github.com/eliontx
status: 404
checked: '2026-08-12'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.